The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures...
At the end of 2021 a new SARS-CoV-2 variant, Omicron, emerged and quickly spread across the world. It has been demonstrated that Omicron’s high number of Spike mutations lead to partial immune...